Dual tyrosine kinase inhibitor for focal adhesion kinase and insulin-like growth factor-I receptor exhibits anticancer effect in esophageal adenocarcinoma in vitro and in vivo.

Source:http://linkedlifedata.com/resource/pubmed/id/18628478

Clin. Cancer Res. 2008 Jul 15 14 14 4631-9

Download in:

View as

General Info

PMID
18628478